CILIQUE NOW AVAILABLE FOR PATIENTS AS AN ALTERNATIVE TO CILEST
Health care professionals may be aware that Cilest (250 micrograms norgestimate / 35 micrograms ethinyl estradiol) is to be discontinued in Ireland from July 2019.
Consilient Health wish to announce that they provide an alternative medication called Cilique. Cilique contains the same active ingredients – 250 micrograms norgestimate / 35 micrograms ethinyl estradiol – as Cilest.
Cilique is now available to Irish patients in a 3 month pack at a net wholesale (MIMS) price at €4.65. Further information on Cilique can be found at www.medicines.ie and www.knowyourcontraceptives.ie.
Cilique is not currently GMS reimbursable, but there will be notification in due course if Cilique gains reimbursement. Consilient Health also supply GMS listed oral contraceptives Violite, Azalia and Ovreena and non-GMS listed oral contraceptives Elvina and Elvinette.
For further queries about Cilique or about any Consilient Health medicines or services, please contact Consilient Health on 01 2057760 or firstname.lastname@example.org.